Aura Biosciences Inc (AURA) - Yalpi foyda normasi

AURA (Aura Bio) - kompaniyaning tovar belgisi

Aura Biosciences, Inc. (AURA) virusli konjugatlar bo'yicha tor ixtisoslashgan loyihalar portfeli tufayli binar xatarlarga duch kelmoqda, bu esa uning yalpi foyda marjasi darajalarida yaqqol ko'rinadi: GURU.Markets grafigidagi vaqt trayektoriyasi ushbu ko'rsatkich 0.00 darajasida ushlab turganini ko'rsatmoqda. Samaradorlik yetakchi onkologlarning jalb qilinishi va moslashuvchan korporativ madaniyat bilan ta'minlanmoqda. Ko'z saratoni terapiyasi sohasidagi monopoliya mavqei Aura Biosciences, Inc. (AURA) kompaniyasiga narxlarni belgilash imkoniyatidan foydalanish va o'z xizmatlari uchun premium narxlarni talab qilish imkonini beradi.

AURA: Aura Biosciences Yalpi marja 04.07.2022 - 21.11.2026

aurabiosciences.com (AURA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi ko'rsatkichlari:
Fundamental baholash:AURA, Aura Biosciences
Aura Biosciences, Inc. brend mahsuloti

Aura Biosciences, Inc. (AURA) lazer-viral ko'z saratoni terapiyasi uchun noyob ekotizimni ishlab chiqmoqda, bu esa bemorlarning yuqori darajada saqlanib qolishini va FDA orqali bozorga tezroq kirishni ta'minlaydi. 0.00 ning joriy qiymati tushumning bevosita ishlab chiqarish xarajatlari chegirilgan qismini aks ettiradi, bu esa investorlarga xomashyo xarajatlarining yakuniy foydaga ta'sirini aniqlash uchun yalpi foyda dinamikasini kuzatish orqali operatsion samaradorlik va biznesning kengayish imkoniyatlarini baholash imkonini beradi.

Toʻgʻridan-toʻgʻri raqobatchilar

Yalpi foyda marjasi BeiGene Ltd. (ONC)|Yalpi foyda bo'yicha rentabellik HALO|Yalpi rentabellik RVMD|Yalpi foyda bo'yicha rentabellik AAPG (Ascentage)|Yalpi foyda bo'yicha rentabellik cgoncology.com CGON|UroGen Pharma - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi BCAX|PSNL - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Erasca Oncology ERAS|delcath.com (DCTH) - Yalpi rentabellik|Y-mAbs Therapeutics - Yalpi foyda normasi|CADL (Candel Therapeutics Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi ARAY (Accuray)|Yalpi foyda bo'yicha rentabellik SLS (SELLAS Life Sciences Group, Inc.)|ACTU - Yalpi foyda marjasi|Yalpi rentabellik Citius Oncology, Inc. CTOR|HURA - Yalpi foyda bo'yicha rentabellik|protaratx.com - Yalpi marja|FATE - Yalpi marja|WHWK: Yalpi marja|TScan Therapeutics (TCRX) - Yalpi marja|Yalpi rentabellik Champions Oncology|Yalpi rentabellik XBIT|Yalpi marja CVM|Yalpi foyda bo'yicha rentabellik OS Therapies Inc. OSTX|Yalpi rentabellik Radiopharm Theranostics Limited RADX|artivabio.com (ARTV) - Yalpi foyda marjasi|ANL - Yalpi rentabellik|Yalpi foyda marjasi verupharma.com|TPST: Yalpi marja|XLO - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Renovaro|Yalpi marja muraloncology.com|Yalpi marja KAPA|Yalpi foyda bo'yicha sotuv rentabelligi OnKure Therapeutics, Inc.|Yalpi marja GDTC (w2.cytomed.sg)|CRIS - Yalpi foyda bo'yicha rentabellik|Apollomics - Yalpi marja|Tharimmune Corp (THAR) - Yalpi foyda bo'yicha rentabellik|ADVB: Yalpi marja|Yalpi foyda bo'yicha rentabellik Genprex|CLDI (Calidi Biotherapeutics, Inc.) - Yalpi marja|Sotuvning yalpi rentabelligi SBFM (Sunshine Biopharma)|Yalpi rentabellik Xenetic Bio (XBIO)|Yalpi rentabellik SLRX (Salarius Pharma)|Kitov Pharma - Yalpi foyda bo'yicha rentabellik|American Oncology Network (AONC) - Yalpi foyda marjasi|BeiGene - Yalpi marja|Checkpoint Therapeutics, Inc. (CKPT) - Yalpi foyda bo'yicha rentabellik|ELEV (Elevation Oncology, Inc.) - Yalpi foyda bo'yicha rentabellik|iCAD Inc. - Yalpi foyda normasi|Yalpi foyda bo'yicha rentabellik IKNA|Yalpi marja notablelabs.com|Yalpi foyda bo'yicha rentabellik VIRX (Viracta Therapeutics Inc.)|MOR - Yalpi foyda marjasi|Yalpi rentabellik NAYA Biosciences NAYA|AAPGV - Yalpi foyda bo'yicha rentabellik